Syncope: interventional treatments
Evidence-based neurology checklist on syncope: interventional treatments: Midodrine: first line The dose is 2.5-15mg 2-4 hourly There is a risk of supine hypertension It should not be taken within 5 hours of bedtime Users should not rest or sleep supine but recumbent It may cause piloerection,…
Midodrine: first line
- The dose is 2.5-15mg 2-4 hourly
- There is a risk of supine hypertension
- It should not be taken within 5 hours of bedtime
- Users should not rest or sleep supine but recumbent
- It may cause piloerection, scalp itching, and urinary retention
- Use with caution in heart and renal failure
Droxidopa: first line
Fludrocortisone: second line
Pyridostigmine
Other drugs to consider
Pacemaker: indications
Treatments of cardiac syncope
References
- Hale GM, Valdes J, Brenner M. The treatment of primary orthostatic hypotension. Ann Pharmacother 2017; 51:417-428.
- Gibbons CH, Schmidt P, Biaggioni I, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol 2017; 264:1567-1582.
- Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009; 30:2631-2671.
- Grubb BP. Neurocardiogenic syncope and related disorders of orthostatic intolerance. Circulation 2005; 111:2997-3006.
- Claassen D, Lew M. Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease. Clin Auton Res 2017; 27(Suppl 1):13-14.
- And 2 more. Subscribe to see the full list